NCT03932552 (LFN-EP) is a NA clinical trial of Exercise in Cirrhosis, sponsored by Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran.

Who is sponsoring NCT03932552?

NCT03932552 is sponsored by Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran.

What drugs are being tested in NCT03932552?

Interventions in NCT03932552: Exercise, nutritional therapy.

What condition does NCT03932552 study?

NCT03932552 studies Cirrhosis, Portal Hypertension, Exercise.

Is NCT03932552 still recruiting?

NCT03932552 is currently completed. Last updated 1 September 2022.

Last reviewed 2022-09-01 · How we verify

NCT03932552: LFN-EP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of a Novel Physical Exercise Program in Patients With Cirrhosis (the LFN-exercise Protocol)

Completed NA Last updated 1 September 2022

What this trial tests

NA trial testing Exercise in Cirrhosis in 28 participants. Completed in 31 January 2020.

Timeline

1 February 2016

Primary endpoint
31 December 2019

31 January 2020

Quick facts

Lead sponsor	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	28
Start date	1 February 2016
Primary completion	31 December 2019
Estimated completion	31 January 2020

Drugs / interventions tested

Exercise
nutritional therapy

Conditions studied

Cirrhosis — all drugs for Cirrhosis →
Portal Hypertension — all drugs for Portal Hypertension →
Exercise — all drugs for Exercise →

Sponsor

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran — full company profile →

Who can join

Adults 18 to 70, any sex, with Cirrhosis or Portal Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the effects of a structured exercise (The LFN-exercise protocol) program plus diet, on cerebral hemodynamics (cerebral blood flow) and hepatic hemodynamics (portal pressure), as well as on nutritional status (body composition and nutritional markers) in order to facilitate the prescription of exercise in patients with cirrhosis.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effect of a monitored exercise protocol in cerebral and hepatic hemodynamics in patients with cirrhosis and portal hypertension.
Macías-Rodríguez RU, Ruiz-Margáin A, Román-Calleja B, Cantú-Brito C, et al · · 2024 · cited 2× · PMID 38008698 · DOI 10.1016/j.dld.2023.11.011

Verify or expand the search:

Other trials of Exercise

Trials testing the same drug.

NCT06231069 — Mixed Exercise Training and Novel Multi-Nutrient Supplementation in Young Adults · NA · withdrawn
NCT07007858 — Effects of High-Velocity Passive Stretch on Spasticity, Function, and Muscle Structure in Spastic CP Children · NA · enrolling by invitation
NCT07589725 — Mulligan Mobilization in Lateral Elbow Tendinopathy · NA · not yet recruiting
NCT07524400 — Effects of Physical Exercise Combined With Transcranial Direct Current Stimulation in Parkinson's Disease · NA · recruiting
NCT06627569 — Exercise Effects on the Neurobiology Underlying Stress-related Eating Behaviors in Veterans · NA · not yet recruiting

Other recruiting trials for Cirrhosis

Currently open trials in the same condition.

NCT07322237 — DICE Study- Diastolic Improvement With Carvedilol & Empagliflozin in Patients With Cirrhosis · Phase 4 · recruiting
NCT07521332 — Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis · Phase 4 · recruiting
NCT07461545 — Efficacy of Apixaban in the Treatment of Portal Vein Thrombosis Occurring More Than One Year After LS · NA · recruiting
NCT07461532 — Efficacy of Apixaban in Treating Portal Vein Thrombosis Occurring More Than One Year After LSD · NA · recruiting
NCT07462091 — Vagus Nerve-guided Laparoscopic Splenectomy and Azygoportal Disconnection · NA · recruiting

Other Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran trials

Trials by the same sponsor.

NCT07004777 — Effect of Consuming n-3 Polyunsaturated Fatty Acids Rich Foods on Triglyceride Concentration and Lipoprotein Composition · NA · recruiting
NCT07018622 — Protecting the Kidney's Proximal Tubules From Platinum-Based Chemotherapy Toxicity · Phase 2 · recruiting
NCT07507981 — Effects of Exercise in Hemodialysis · NA · completed
NCT06953193 — Intraoperative Hypotension in Pancreatoduodenectomy: A Randomized Trial of General Versus Combined Anesthesia · NA · recruiting
NCT06556836 — "Diagnostic Accuracy of Ultrasound Compared to Epidurography for Epidural Catheter Localization" · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03932552 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Last refreshed: 1 September 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03932552.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing